Startup
Aerska
Startup · Dublin, Ireland
Aerska is a Dublin-based RNA medicines biotech company that uses proprietary brain shuttle technology to overcome the blood-brain barrier and deliver RNAi therapies for neurological diseases such as Alzheimer's and Parkinson's. Founded in 2025 by Jack O'Meara, Dave Hardwicke, and Stu Milstein, the company emerged from stealth in October 2025 with a $21 million seed round, then closed a $39 million Series A in February 2026 led by EQT Dementia Fund and age1, bringing total funding to $60 million.
Connection map
Affiliation
Drag nodes to rearrange · scroll or pinch to zoom · click a node to open it